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PHeart Rhythm Disorders
Short- and Long-Term Prognosis of Syncope,
Risk Factors, and Role of Hospital Admission
Results From the STePS (Short-Term Prognosis of Syncope) Study
Giorgio Costantino, MD,* Francesca Perego, MD,* Franca Dipaola, MD,*
Marta Borella, MD,* Andrea Galli, MD,* Giulia Cantoni, MD,† Simonetta Dell’Orto, MD,‡
Simonetta Dassi, MD,§ Nicola Filardo, MD,* Pier Giorgio Duca, MD, Nicola Montano, MD, PHD,*
Raffaello Furlan, MD,* on behalf of the STePS Investigators
Milan, Italy
Objective We sought to assess short- and long-term prognosis of syncope and associated risk factors.
Background Syncope is a common clinical event, but our knowledge of its short-term outcome is largely incomplete. Further,
it is unknown whether hospital admission might positively affect a patient’s syncope prognosis.
Methods We screened 2,775 consecutive subjects who presented for syncope at 4 emergency departments between Jan-
uary and July 2004. Short- and long-term severe outcomes (i.e., death and major therapeutic procedures) and
related risk factors were compared in all enrolled patients arrayed according to hospital admission or discharge.
Results A total of 676 subjects were included in the study. Forty-one subjects (6.1%) experienced severe outcomes (5
deaths, 0.7%; 36 major therapeutic procedures, 5.4%) in the 10 days after presentation. An abnormal electro-
cardiogram, concomitant trauma, absence of symptoms of impending syncope, and male gender were associ-
ated with short-term unfavorable outcomes. Long-term severe outcomes were 9.3% (40 deaths, 6.0%; 22 major
therapeutic procedures, 3.3%), and their occurrence was correlated with an age 65 years, history of neo-
plasms, cerebrovascular diseases, structural heart diseases, and ventricular arrhythmias. Short-term major ther-
apeutic procedures were more common (p  0.05) in subjects who had been admitted to hospital (13.3%) than
in discharged (1.6%), whereas mortality was similar. One-year mortality was greater (p  0.05) in admitted
(14.7%) than in discharged (1.8%) patients.
Conclusions Risk factors for short- and long-term adverse outcomes after syncope differed. Hospital admission favorably influ-
enced syncope short term prognosis. Instead, 1-year mortality was unaffected by hospital admission and related to
comorbidity. (J Am Coll Cardiol 2008;51:276–83) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.059l
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tyncope is estimated to affect 6.2/1,000 person-years (1)
nd to account for up to 3% of all emergency department
ED) visits and 6% of hospital admissions (2). Syncope may
e the final common symptom for a number of clinical
onditions spanning from benign conditions to life-
hreatening diseases. Accordingly, its prognosis varies
idely and 1-year mortality may range from 0% in the case
f vasovagal events up to 30% in the presence of heart
isease (2–6).
rom the *Syncope Unit, Internal Medicine II, “L. Sacco” Hospital, University of
ilan, Milan, Italy; †Emergency Medicine, “Fatebenefratelli” Hospital, Milan, Italy;
Cardiology, “Uboldo” Hospital, Cernusco s. Naviglio, Milan, Italy; §Internal
edicine, “S. Corona” Hospital, Garbagnate Milanese, Milan, Italy; and Medical
tatistics, Institute of Clinical Science “L.Sacco,” University of Milan, Milan, Italy.
his study was supported by a donation from Autogrill S.p.A.w
Manuscript received April 27, 2007; revised manuscript received August 7, 2007,
ccepted August 13, 2007.Hospital admission is frequent in patients suffering from
oss of consciousness because of difficulties in promptly
ddressing the causes of syncope in the emergency setting,
oncern about potentially fatal ventricular arrhythmia and
udden death (7), and the possibility, as yet not supported
See page 284
y specific studies, that prompt in-hospital evaluation might
avorably affect the outcome (8–10). In addition, prognostic
cores, meant to provide emergency physicians with reliable
uidelines for hospital admission/discharge, have been ob-
ained from mortality and morbidity at 6 or 12 months after
he sentinel event (7,11–13). This risk stratification ap-
roach implies that risk factors for 1-year adverse outcomes
re identical to risk factors affecting the short-term (i.e., up
o 10 days) clinical outcome, an assumption, however, that
arrants further supporting evidence.
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January 22, 2008:276–83 Prognosis of SyncopeTo date, few investigations have addressed the problem of
ortality and the rate of severe outcomes in the period
mmediately after syncope (14,15). To the best of our knowl-
dge, only one recent prospective single-center study was
pecifically designed to assess the occurrence of unfavorable
utcomes within 7 days from the ED visit (14). However, in
hat study, serious outcomes also included myocardial in-
arction, pulmonary embolism, stroke, and other severe
iseases that were likely diagnosed primarily in the ED,
ith syncope being an ancillary symptom. These diseases
re characterized by their own short-term mortality that in
urn may affect short-term prognosis of syncope.
In the present prospective study, we aimed to assess the
hort- and long-term prognosis of syncope by evaluating
ortality, the rate of major therapeutic procedures, and the
redictors of adverse events within 10 days and 1 year from
he visit in the ED. In addition, we compared the rate of
evere outcomes in admitted and discharged patients both in
he short- and long-term periods to determine whether
ospital admission favorably affected prognosis of syncope.
ethods
opulation. This prospective study included all consecu-
ive subjects older than 18 years of age who presented
eporting syncope within the previous 48 h at the ED of 4
eneral hospitals in Milan area (Sacco, Milan; Fatebene-
ratelli, Milan; Uboldo, Cernusco s/N; and S. Corona,
arbagnate Milanese), between the January 23 and July 31,
004.
As shown in Figure 1, 2,775 patients were screened on the
asis of the following triaging diagnoses: syncope, loss of
Figure 1 Flow Diagram of the
Screened and Enrolled Population
Flow diagrams of the enrolled population and short-term and 1-year follow up.aonsciousness, pre-syncope, faint-
ng, collapse, light-headedness,
izziness, falls, seizures, head inju-
ies, and bone fractures. The fol-
owing exclusion criteria were used
o ultimately determine our target
opulation: 1) the presence of clin-
cal conditions primarily con-
rmed in the ED that would have
equired hospital admission inde-
endently of the syncope such as myocardial infarction, acute
ulmonary embolism, subarachnoidal hemorrhage, stroke, car-
iac arrest, sustained bradycardia (35 beats/min), complete
trioventricular block, sustained ventricular tachycardia; 2) a
eferred head injury preceding the loss of consciousness; 3) a
eferred nonspontaneous return to consciousness; 4) nonsyn-
opal syndromes such as light-headedness, vertigo, coma,
hock, and seizure; 5) associated diseases with a prognosis 6
onths; 6) recent alcohol or drug abuse; 7) unwillingness to
rovide consent to participate in the study; and 8) unfeasible
ollow-up (foreigners, homeless).
The study was approved by the Ethical Committee on
uman Research of the Coordinating Centre (Ospedale
L.Sacco”), and participants provided written consent. Oral
onsent was obtained in patients discharged from ED that
ere interviewed by phone.
efinitions. Syncope was defined as a transient loss of
onsciousness associated with the inability to maintain
ostural tone, followed by spontaneous recovery (5). Severe
utcomes included death, the need for major therapeutic
rocedures, and early (within 10 days) readmission to
ospital. We defined as major therapeutic procedures car-
iopulmonary resuscitation, pacemaker or implantable
ardioverter-defibrillator insertion, intensive care unit ad-
ittance, and acute antiarrhythmic therapy. We considered
nly those procedures undertaken after the patient was
ospitalized from the ED or discharged. As for early
eadmission to hospital, in keeping with a previous study
14), we assumed that any patient discharged from ED after
yncope and then readmitted to hospital for the same or
imilar symptoms was to be considered at high risk for
eveloping a severe outcome.
Electrocardiogram (ECG) was defined as abnormal in
he presence of any of the following: 1) atrial fibrillation or
achycardia; 2) sinus pause 2 s; 3) sinus bradycardia with
eart rate ranging between 35 and 45 beats/min; 4) con-
uction disorders (i.e., bundle branch block, second-degree
obitz I atrioventricular block); 5) ECG signs of previous
yocardial infarction or ventricular hypertrophy; and 6)
ultiple premature ventricular beats. Short-term and 1-year
ortality rates were calculated between day 0 and day 10 or
etween day 11 and 365 from the index event, respectively.
tudy end points. The primary aim of the present study
as to assess the rate of short- and long-term severe
utcomes after syncope and to compare the risk factors
Abbreviations
and Acronyms
CI  confidence interval
ECG  electrocardiogram/
electrocardiographic
ED  emergency
department
OR  odds ratiossociated with the observed short- and long-term adverse
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Prognosis of Syncope January 22, 2008:276–83linical events. Six participating physicians obtained the ED
eports to perform the initial screening; furthermore, they
romptly evaluated all the admitted patients in the different
ivisions. As to the discharged subjects, they were either
irectly evaluated before discharge or surveyed within 2 days
y phone and subsequently within 10 days from the target
vent, using a 10-item questionnaire. One year follow-up
ata were collected by the use of phone interviews. If
atients were not reachable or unable to talk, their relatives
r general practitioners were interviewed. A regional data-
ase was consulted to evaluate 1-year mortality of 78
atients who could not be reached by phone.
Our second aim was to evaluate whether hospitalization
ffected the prognosis of these patients. To achieve this goal,
ortality and major therapeutic procedure rates for admit-
ed and discharged patients were evaluated both in the short
nd long term. However, it must be pointed out that the
recise evaluation of this point remains speculative because
t is impossible to follow an admitted/discharged random-
zation procedure for ethical reasons.
ata management and statistical analysis. All data were
ollected by a physician of the coordinating center and
tored in a prospectively designed database. Descriptive
tatistics for continuous (age) and categorical variables were
sed to summarize the baseline characteristics of patients
nrolled, admitted to hospital and discharged. Differences
ere evaluated with the Student t test, chi-square test, and
isher exact test (5 expected events in a cell of the
ontingency table), whenever appropriate. All analyses were
-tailed, and p values 0.05 were considered significant.
Potential predictors of hospital admission and of short-
nd long-term severe outcomes were first individually eval-
ated and then analyzed by multivariate logistic regression
nalysis with a stepwise backward selection strategy. The
ffect of hospital admission on 1-year mortality, adjusted for
isk factors, also was evaluated applying the Cox regression.
ll analyses were performed using SPSS 14.0 for Windows
SPSS Inc., Chicago, Illinois).
esults
s shown in Figure 1 and Table 1, 676 patients satisfied
he inclusion criteria and were enrolled in the study;
,099 subjects were not included. Among these, 1,986
ad no definite diagnosis of syncope according to our
efinition, whereas 113 met the exclusion criteria. We
ould not reach 6 patients for the scheduled 10-day
ollow-up. Short-term prognosis analysis of syncope was
hus performed on 670 patients. Of note, 452 (67%)
atients were directly discharged from ED and the remain-
ng patients were hospitalized. One-year follow-up was ob-
ained for 667 patients. The demographic features and the
linical characteristics of the study population are summarized
n Table 1. wevere short-term outcomes and associated risk factors.
ithin 10 days from the examination in the ED, 41
ubjects (6.1%) exhibited severe outcomes, represented by 5
eaths (0.7 %) and 36 major therapeutic procedures or early
eadmission (5.4%) (Table 2). Table 3 details the causes of
eath, along with time of occurrence since the visit in the
D. All patients except for one were older than 70 years. Of
nterest, 4 of 5 patient deaths happened within 48 h of
edical evaluation in the ED. Table 4 summarizes the
umber and types of severe outcomes other than death.
At univariate analysis, risk factors significantly associated
ith severe short-term outcomes were: age older than 65
ears, male gender, and the coexistence at presentation of
tructural heart disease, heart failure, chronic obstructive
ulmonary disease, trauma, abnormal ECG, and the ab-
ence of preceding symptoms (Table 5). At multivariate
nalysis, an abnormal ECG at presentation (adjusted odds
atio [OR] 6.9; 95% confidence interval [CI] 3.1 to 15.1), a
oncomitant trauma (OR 2.9; 95% CI 1.4 to 5.9), absence
f previous symptoms (OR 2.4; 95% CI 1.2 to 4.8), and
ale gender (OR 2.2; 95% CI 1.0 to 4.5) were independent
isk factors for the development of severe adverse outcomes
n the short term (Table 5).
ong-term mortality and severe outcomes. The 1-year
verall mortality was 6.0% (40 deaths). There were 22
3.3%) severe outcomes other than death. At univariate
nalysis, risk factors significantly associated with the long-
erm (from the 11th day up to 1 year since ED visit) severe
utcomes were age older than 65 years, a history of
ypertension, structural heart disease, heart failure, ventric-
lar arrhythmias, cerebrovascular diseases, chronic obstruc-
ive pulmonary disease, neoplasms, or abnormal ECG at
D presentation (Table 6). At multivariate analysis, risk
actors significantly associated with adverse outcomes in-
luded age older than 65 years (OR 3.4; 95% CI 1.6 to 7.4)
nd the coexistence at presentation of neoplasms (OR 3.2;
5% CI 1.6 to 6.5), cerebrovascular diseases (OR 2.5; 95%
I 1.3 to 4.7), structural heart diseases (OR 2.3; 95% CI 1.3
o 4.2), or ventricular arrhythmias (OR 3.9; 95% CI 1.0 to
5.3) (Table 6). Table 7 specifies the causes of death that
ccurred from the 11th day up to 1 year since ED visit.
ffects of hospital admission on syncope short- and
ong-term prognoses. The demographic and clinical fea-
ures of all patients arranged according to hospital admis-
ion or discharge are summarized in Table 1. Please notice
hat about half of admitted patients were older than 65 years
nd characterized by a worse medical history than dis-
harged subjects, particularly as far as hypertension, struc-
ural heart disease, arrhythmias, cerebrovascular disease, and
hronic obstructive pulmonary disease were concerned.
Within 10 days of syncope (Table 2), the rate of severe
utcomes was significantly greater (p  0.01) in admitted
14.7%) than in discharged (2.0%) patients. Death occurred
n 3 hospitalized (1.4%) and in 2 discharged (0.4%) patients.
he 1-year mortality in admitted patients (n  32, 14.7%)
as significantly greater (p  0.0001) than that observed in
d
a
a
(
D
I
m
a
o
s
i
6
t
t
g
w
w
o
t
f
c
g
t
a
t
S
f
m
i
p
p
(
dent t t
279JACC Vol. 51, No. 3, 2008 Costantino et al.
January 22, 2008:276–83 Prognosis of Syncopeischarged subjects (n  8, 1.8%) (Fig. 2). When the
nalysis was adjusted for long-term risk factors, hospital
dmission remained associated with the worst prognosis
Table 8).
iscussion
n the present prospective multicenter study, we addressed 3
ajor complementary questions. What is the rate of deaths
nd unfavorable events and what are the predictors of poor
utcome within 10 days from the onset of syncope? Are
hort- and long-term risk factors for adverse outcomes
dentical? Does hospital admission affect prognosis?
Our data indicate that 1) within 10 days from syncope,
.1% of patients suffered from serious outcomes, whereas
he presence of abnormal ECG at presentation, concomi-
ant trauma, absence of presyncopal symptoms, and male
ender were found to be independent risk factors associated
Demographic and Clinical Features of the Popul
Table 1 Demographic and Clinical Features
To
(n 
Age  SD, yrs 59
18–44 194
45–65 154
65 322
Gender
Women 376
Men 294
Medical history
Hypertension 265
Structural heart disease 164
Heart failure 29
Ventricular arrhythmias 12
Cerebrovascular disease 86
Neurological disease 65
Diabetes mellitus 66
Chronic obstructive pulmonary disease 53
Neoplasm 53
Index syncope history
Supine/sitting 157
Upright posture 498
During exercise 15
First episode 290
Trauma 161
Abnormal electrocardiogram at presentation 218
Absence of preceding symptoms 190
Values expressed as n (%). p value, admitted versus discharged. *Stu
Adverse Short-Term Events in Admitted and Disc
Table 2 Adverse Short-Term Events in Admi
Total
(n  670)
Death 5 (0.7)
Major therapeutic procedures
and early readmission
36 (5.4)
Severe outcomes 41 (6.1)Values expressed as n (%). *p  0.01 admitted versus discharged. †Fisher eith a poor outcome; 2) short- and long-term risk factors
ere different; and 3) within 10 days from syncope, the rate
f major therapeutic procedures was greater in admitted
han in discharged patients, indicating a potentially
avorable effect of hospital admission on the short-term
linical outcome. However, the 1-year mortality was
reater in patients who were hospitalized compared with
hose who were discharged. Thus, hospital admission
fter syncope was unlikely to modify the patient’s long
erm clinical history.
hort-term prognosis of syncope and associated risk
actors. So far, most of the available data on short-term
ortality and adverse outcomes after syncope have been
ndirectly generated from studies intended for different
urposes (13,16,17). Although in-hospital mortality of ap-
roximately 1% can be inferred from such studies
13,16,17), an accurate estimate of overall short-term prog-
Studied
e Population Studied
Admitted
(n  218)
Discharged
(n  452) p Value
72 15 53 21 0.01*
13 (6.0) 181 (40.0)
39 (17.9) 115 (25.5) 0.01†
166 (76.1) 156 (34.5)
114 (52.3) 262 (58.0) NS†
104 (47.7) 190 (42.0) NS†
124 (56.9) 141 (31.2) 0.01†
69 (31.7) 95 (21.0) 0.05†
13 (6.0) 16 (3.5) NS‡
7 (3.2) 5 (1.1) NS‡
48 (22.0) 38 (8.4) 0.01†
23 (10.6) 42 (9.3) NS†
30 (13.8) 36 (8.0) 0.05†
27 (12.4) 26 (5.8) 0.05†
32 (14.7) 21 (4.6) 0.01†
56 (25.7) 101 (22.4) NS†
158 (72.5) 340 (75.2) NS†
4 (1.8) 11 (2.4) NS‡
104 (47.7) 186 (41.2) NS†
74 (33.9) 87 (19.2) 0.01†
113 (51.8) 105 (23.2) 0.01†
96 (44.0) 94 (20.8) 0.01†
est; †chi-square test; ‡Fisher exact test.
ed Patients
nd Discharged Patients
Admitted
(n  218)
Discharged
(n  452) p Value
3 (1.4) 2 (0.4) NS†
29 (13.3) 7 (1.6)* 0.01‡
32 (14.7) 9 (2.0)* 0.01‡ation
of th
tal
670)
22
(29.0)
(23.0)
(48.0)
(56.1)
(43.9)
(39.6)
(24.5)
(4.3)
(1.8)
(12.8)
(9.7)
(9.9)
(7.9)
(7.9)
(23.4)
(74.3)
(2.3)
(43.3)
(24.0)
(32.5)
(28.4)harg
tted axact test; ‡chi-square test.
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Prognosis of Syncope January 22, 2008:276–83osis of syncope is impossible because no follow-up has
een systematically undertaken for subjects discharged from
he ED. Only one study was specifically designed to evaluate
he rate of severe outcomes within 7 days from syncope and
eported such rate to be 11.5%, with a death rate of 0.7%
14). Whereas deaths are comparable, observed adverse
vents were greater than those found in our study. This
ight be the result of differences either related to the
arious types of severe outcomes considered and/or to
nclusion/exclusion criteria characterizing the 2 studies. As
o this latter point, it has to be noted that we chose not to
nclude cases in which the major diagnoses (such as myo-
ardial infarction, pulmonary embolism, stroke) were done
rimarily in the ED, as it was in the case of the study by
uinn et al. (14). Indeed, we reasoned that such diseases
ould have affected syncope short-term outcome by their
wn poor prognosis. Such a more restrictive approach
ompared with other studies entails the need of limiting
onclusions to our selected population.
In our study, short-term overall unfavorable events were
bserved in 41 cases and included 5 fatalities. Interestingly,
Reasons and Time of Death, Age, and Gender oWho Died With n 10 Days From the Emergency
Table 3 Reasons and Time of Death, Age, aWho Died Within 10 Days From the
Patient # Cause of Death
Elaps
From
1 DIC 24
2 Acute pulmonary edema 24
3 Aortic dissection 48
4 Pulmonary Embolism 24
5 Stroke 10
Causes of death confirmed by autopsy in Patients #1 and #2, by comp
Patients #4 and #5. A causal relationship between syncope and death
the 2 clinical events. A more weak relationship characterizes the rem
DIC  disseminated intravascular coagulation.
ajor Therapeutic Procedures and Earlyeadmission Within 10 Days From Syncope
Table 4 Major Therapeutic Procedures and EarlyReadmission Within 10 Days From Syncope
Patients, n
Clinical Conditions Leading to
Major Therapeutic Procedures
PM 21 Complete AV block, Mobitz type 2,
second-degree AV block,
sustained bradycardia, carotid
sinus syndrome
ICD 1 Malignant arrhythmias with severe
left ventricular disfunction
CPR 1 Myocardial infarction with
respiratory failure
Intensive care unit
admission
5 Pulmonary edema, acute respiratory
failure, subarachnoid hemorrhage
Intensive care unit
admission  ICD
1 Malignant arrhythmias with severe
left ventricular disfunction
Antiarrhythmic therapy 3 High ventricular rate atrial flutter or
atrial fibrillation with heart failure
Early readmission for
syncope recurrence
4
Total 36V  atrioventricular; CPR  cardiopulmonary resuscitation; ICD  implantable cardioverter-
efibrillator; PM  pacemaker implant.
*subjects died within 48 h from the sentinel event,
ighlighting the importance of a prompt risk stratification
trategy after syncope possibly best achieved by specifically
esigned facilities such as the syncope unit (9).
An important result of the present study is the finding
hat trauma, an abnormal ECG, the absence of symptoms
receding syncope, and male gender were independent risk
actors for developing adverse events within 10 days from
he index episode. To some extent, these risk factors diverge
h Patientrtment (ED) Visit
nder of Each Patient
rgency Department (ED) Visit
e
sit Admitted Age (yrs) Gender
Yes 62 M
Yes 90 F
Yes 83 F
No 72 M
No 95 M
mography scanning in Patient #3, and based on clinical diagnosis for
24 to 48 h is highly likely because of the very short time lag between
yncope that is the one associated with stroke and death at 10 days.
isk Factors for Severe Short-Term Outcomesithin 10 Days (Univariate and Multivariatenalysis)
Table 5
Risk Factors for Severe Short-Term Outcomes
Within 10 Days (Univariate and Multivariate
Analysis)
Severe Outcomes
Yes  41 No  629 p Value
Age 65 yrs, n (%) 32 (78) 290 (46) 0.000*
Male gender, n (%) 27 (66) 267 (42) 0.005*
Medical history, n (%)
Hypertension 18 (44) 247 (39) 0.620*
Structural heart disease 20 (49) 144 (23) 0.001*
Heart failure 5 (12) 24 (4) 0.027†
Ventricular arrhythmias 1 (2) 11 (2) 0.530†
Cerebrovascular diseases 8 (20) 78 (12) 0.220*
Neurological diseases 2 (5) 63 (10) 0.420*
Diabetes mellitus 4 (10) 62 (10) 1.000*
COPD* 7 (17) 46 (7) 0.035*
Neoplasms 5 (12) 48 (8) 0.360*
Trauma, n (%) 17 (42) 144 (23) 0.013*
Abnormal ECG at presentation,
n (%)
30 (73) 188 (30) 0.000*
Absence of symptoms
preceding syncope, n (%)
19 (46) 171 (27) 0.012*
Logistic Multivariate Regression
(Stepwise Backward)
Adjusted
Odds Ratio
95%
Confidence
Interval p Value
Abnormal electrocardiogram
at presentation
6.9 3.1–15.1 0.000*
Trauma 2.9 1.4–5.9 0.004*
Absence of symptoms
preceding syncope
2.4 1.2–4.8 0.016*
Male gender 2.2 1.0–4.5 0.037*f EacDepa
nd Ge
Eme
ed Tim
ED Vi
h
h
h
h
days
uted to
withinChi-square test; †Fisher exact test.
COPD  chronic obstructive pulmonary disease; ECG  electrocardiogram.
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January 22, 2008:276–83 Prognosis of Syncoperom those identified by the San Francisco Syncope Rule
14). Only ECG abnormalities are recognized as risk factors
n both studies. Similar to what has been previously ob-
erved, dissimilarities in the recruitment criteria may ac-
ount, at least in part, for such discrepancies. We hypoth-
size that the prompt identification of short-term risk
actors may help emergency physicians in their decision
aking process and in turn reduce the number of inappro-
riate hospital admission.
ong-term mortality and severe outcomes. A number of
tudies have addressed the problem of syncope prognosis,
isk Factors for Severe Outcomes From the 11thay Up to 1 Year After the ED Vi it (Univariate andultiv riate An lysis)
Table 6
Risk Factors for Severe Outcomes From the 11th
Day Up to 1 Year After the ED Visit (Univariate and
Multivariate Analysis)
Severe Outcomes
Yes  64 No  598 p Value
Age 65 yrs, n (%) 54 (84) 264 (44) 0.000*
Male gender, n (%) 31 (48) 258 (43) 0.430*
Medical history, n (%)
Hypertension 42 (66) 220 (37) 0.000*
Structural heart disease 34 (53) 125 (21) 0.000*
Heart failure 9 (14) 20 (3) 0.001†
Ventricular arrhythmias 4 (6) 8 (1) 0.022†
Cerebrovascular diseases 22 (34) 63 (11) 0.000*
Neurological diseases 8 (13) 57 (10) 0.500*
Diabetes mellitus 10 (16) 56 (9) 0.120*
COPD* 12 (19) 41 (7) 0.003*
Neoplasms 16 (25) 37 (6) 0.000*
Trauma, n (%) 15 (23) 145 (24) 1.000*
Abnormal ECG at
presentation, n (%)
39 (61) 176 (29) 0.000*
Absence of symptoms
preceding syncope, n (%)
23 (36) 165 (28) 0.190*
Logistic Multivariate Regression
(Stepwise Backward)
Adjusted
Odds Ratio
95%
Confidence
Interval p Value
Age 65 yrs 3.4 1.6–7.4 0.001*
Neoplasms 3.2 1.6–6.5 0.001*
Cerebrovascular diseases 2.5 1.3–4.7 0.006*
Structural heart disease 2.3 1.3–4.2 0.004*
Ventricular arrhythmias 3.9 1.0–15.3 0.049*
Chi-square test; †Fisher exact test.
COPD  chronic obstructive pulmonary disease; other abbreviations as in Tables 3 and 5.
auses of Death From 11th Day Up toYear After the Emergency epartment Visit
Table 7 Causes of Death From 11th Day Up to1 Year After the Emergency Department Visit
Causes of Death Patients, n
Undetermined 16
Sudden death 3
Pulmonary diseases 7
Cardiovascular diseases 5
Cerebrovascular diseases 3
Neoplasms 3
Others 3Total 40
*ighlighting its remarkable variability according to the
ifferent causes that underlie the loss of consciousness
1,3,4,18–20). In particular, cardiac syncope was character-
zed by the worst prognosis (1) compared with the virtual
bsence of mortality at 12 months in the case of vasovagal
vents (1,3,5).
It has to be noted that guidelines (2,5,21,22) and prog-
ostic scores used in the emergency setting, aimed at
tratifying patients according to risk (7,11–13), have been
erived from data at 6 or 12 months after the index event
3,11,12,19,23,24). Our data indicate that long- and short-
erm risk factors are significantly different. Therefore, as
ong as 1-year follow-up scores are not validated also in the
hort-term period, the use of long-term risk factors to
tratify patient risk in the period immediately following
yncope might ultimately prove deceptive.
oes hospital admission affect syncope prognosis? Pa-
ients suffering from loss of consciousness are often admit-
ed because of the difficulties in a rapid etiology evaluation
n the ED environment, thus increasing the ultimate costs
f the diagnostic work-up (25,26), particularly when no
tandardized decision-making approach is available (27).
ccordingly, whether or not hospital admission influences
he outcome of syncope (28) becomes an important clinical
ssue. From a methodological standpoint, we note that the
igorous evaluation of the prognostic effects of hospitaliza-
ion could have been achieved only by an “admitted/
Figure 2 Survival Curves of Patients Admitted to
the Hospital and Discharged From the ED
Comparison of 1-year survival curves of patients admitted to hospital and dis-
charged from the emergency department (ED). Notice that patients admitted to
hospital after syncope had greater (p  0.0001, log-rank test) rates of mortal-
ity than discharged subjects. These differences were also confirmed when
adjusting for long-term risk factors.
ospital Admission Adjusted Withng-Term Risk Factors (Logist c Regression)
Table 8 Hospital Admission Adjusted WithLong-Term Risk Factors (Logistic Regression)
Adjusted
Odds Ratio
95%
Confidence
Interval p Value
Neoplasms 4.4 1.9–10.2 0.001*
Structural heart disease 2.8 1.3–5.9 0.008*
Age 3.3 2.0–5.5 0.000*
Hospital admission 4.1 1.7–9.7 0.001*Chi-square test.
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Prognosis of Syncope January 22, 2008:276–83ischarged” randomization procedure that, however, was
ot feasible for obvious ethical reasons.
Nonetheless, it is of note that 1) our observed rate of
ajor therapeutic procedures was greater in admitted than
n discharged patients; 2) mortality rates were similar in
oth groups; and 3) all subjects who underwent a major
herapeutic procedures could be subsequently discharged.
aken together, these findings indirectly suggest that hos-
ital admission positively affects the short-term clinical
utcome in patients suffering from syncope. However, such
likely favorable short-term effect does not necessarily
mply a better prognosis in the long-term period.
Indeed, as a consequence of the fact that the only clinical
udgment of the emergency physician directed the admit-
ing/discharging procedures, admitted patients were “sicker”
han discharged patients, being characterized by a worse
edical history. In addition, almost 50% of admitted
ubjects were older than 65 years of age. Therefore, in the
resent study, it was not surprising that data at 1-year
ndicated that admitted patients were characterized by a
reater mortality than discharged cases, despite hospitaliza-
ion and treatment of the presumptive cause of syncope.
ndeed, this finding is likely to reflect the importance of
omorbidities, as suggested by long-term risk factors such
s cardiac and cerebrovascular diseases and neoplasms.
herefore, hospital admission seems to favorably modify
he short-term prognosis of syncope possibly because of
he promptly undertaken life-saving measures, whereas
o-morbidity seemed to play a pivotal role in long-term
yncope prognosis.
tudy limitations. We are aware of the limitations of the
resent study. First, as in all observational studies, we could
ot account for additional and possibly less objective factors
hat might have ultimately influenced the attending physi-
ian in the decision to admit/discharge the patient. Second,
o specific protocol was determined a priori and followed
hereas the decision on possible patient admission or
ischarge was based only on the physician’s clinical experi-
nce. Third, we focused on a composite end point (i.e.,
evere outcomes), which combined mortality with the rate
f those major therapeutic procedures that were assumed,
lthough not proved, to save patient lives.
onclusions
yncope is a common clinical event, but data on its
hort-term prognosis and comparison with long-term prog-
osis are still scant. In the present study, we addressed these
ssues and observed that the hours immediately after syn-
ope were characterized by the highest risk for death,
hereas co-morbidity seemed to play the major role in
etermining 1-year mortality. We also found that risk
actors for short and long-term adverse outcomes after
yncope were different, thus implying that prognostic scores
alidated on short-term risk factors are required to properly
tratify the patient’s risk in the ED. Finally, hospitaldmission seemed to positively affect prognosis within 10
ays of syncope, but did not appear to influence the 1-year
ortality rate. The latter is likely to be related to the severity
f concomitant diseases.
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APPENDIX
articipating hospitals and investigators: L. Sacco, Milano: C. Selmi, A.
ngrassano, A. Vicenzi, L. Malerba, K. Colombo, E. Maltana; Fatebene-
ratelli, Milano: E. Omboni, A. Villa, O. Milani; Uboldo, Cernusco s/N: E. M.
reco, M. Sfolcini, C. Riva, A. Tresoldi; S.Corona, Garbagnate: D. Som-
ariva, R. Turconi.
